Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
Background: Metastatic triple-negative breast cancer (TNBC) is a heterogeneous and incurable disease. Numerous studies have been conducted to seek molecular targets to treat TNBC effectively, but chemotherapy is still the main choice for patients with TNBC. We have previously presented evidence of t...
| Publicado en: | Breast Cancer Research Vol. 20; no. 1 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
6/14/2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |